Status:
COMPLETED
EBV-associated Diffuse Large B Cell Lymphoma
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
To Characterize and Compare Clinical, Pathological and Molecular Features
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to characterize and compare clinical, pathological (histology, immunophenotype) and molecular features of EBV-related GZL and DLBCL: do they belong to the same entity or to tw...
Detailed Description
Recent progresses in the understanding of lymphoma biology allowed the identification of new categories in the WHO classification of lymphoid neoplasm. Among these new entities, grey zone lymphoma (GZ...
Eligibility Criteria
Inclusion
- all EBV-related GZL and DLBCL in immunocompetent patients
- Age minimum: 18 years old
Exclusion
- Another diagnosis than EBV-related GZL and DLBCL
- \<18 years old
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03378947
Start Date
June 1 2017
End Date
November 1 2018
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HCL
Lyon, Pierre Bénite, France, 69310